Lumenis Named “Best Overall Medical Device Company” in 2021 MedTech Breakthrough Awards
Lumenis announced that it has been selected as the “Best Overall Medical Device Company” in the MedTech Breakthrough Awards. MedTech Breakthrough is an independent market intelligence organization that honors excellence and recognizes the top companies, technologies and products in the global health and medical technology market. This year, MedTech reviewed roughly 3,850 nominations from 17 countries to select winners in 97 categories, including Lumenis’ highest recognition for a medical device company. In 2020, Lumenis won the MedTech Breakthrough Award for “Best New Surgical Technology Solution” for its MOSES Technology.
“For decades, Lumenis has created groundbreaking technologies to address previously untreatable conditions, as well as to revolutionize existing treatments in each and every sector it touches,” James Johnson, managing director, MedTech Breakthrough, said in a company news release. “With innovative, minimally invasive solutions that generate superior clinical outcomes, Lumenis has broken through the crowded medical device field to win our ‘Best Overall Medical Device Company’ for 2021.”
MedTech recognized that in the fraught healthcare environment of the past year, Lumenis has pushed forward with groundbreaking advances, launching new solutions in multiple sectors.
In urology, Lumenis launched the next-generation MOSES 2.0, revolutionizing the field of laser lithotripsy and BPH treatments. MOSES 2.0 improves clinical outcomes, surgical efficiency and intraoperative bleeding to such a degree that it enables the gold-standard holmium laser enucleation surgery for enlarged prostate to become a catheter-free, same-day discharge procedure. In vision, Lumenis’ IPL device with OPT was the first and only such device to receive an FDA De Novo authorization for improving signs of dry eye disease due to meibomian gland dysfunction. Subsequent to the FDA approval, Lumenis launched the patented OptiLight system, elevating dry eye management. In the field of aesthetics, Lumenis introduced three new technologies: the Stellar M22, a powerful multi-application platform for over 30 skin conditions and hair removal; the NuEra Tight with FocalRF technology, a breakthrough in personalized non-invasive, radio frequency (RF) body-shaping treatments; and the LightSheer Quattro, a flagship solution in diode laser hair removal.